EUVIMEDEUVIMED entdecken
Crossref

LLP2A-Ale, a Novel PDC Drug, Attenuates Osteoarthritis Progression by Modulating Subchondral Bone Remodeling and Chondroprotective Pathways in Osteoarthritis Models

Yonglong Cai, Xuexiang Xiang, Min Jiang, Charles Chen, Jiwei Chen, Nancy Lane, Wei Yao

Osteoarthritis and Cartilage · 2026-04 · 34 · S61-S62

DOI: 10.1016/j.joca.2026.01.059 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Osteoarthritis and Cartilage, 2026-04. Verfasst von Yonglong Cai und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Cai, Y., Xiang, X., Jiang, M., Chen, C., Chen, J., Lane, N., & Yao, W. (2026). LLP2A-Ale, a Novel PDC Drug, Attenuates Osteoarthritis Progression by Modulating Subchondral Bone Remodeling and Chondroprotective Pathways in Osteoarthritis Models. Osteoarthritis and Cartilage, 34, S61-S62. https://doi.org/10.1016/j.joca.2026.01.059

Vancouver

Cai Y, Xiang X, Jiang M, Chen C, Chen J, Lane N, et al. LLP2A-Ale, a Novel PDC Drug, Attenuates Osteoarthritis Progression by Modulating Subchondral Bone Remodeling and Chondroprotective Pathways in Osteoarthritis Models. Osteoarthritis and Cartilage. 2026;34:S61-S62. doi:10.1016/j.joca.2026.01.059

BibTeX
@article{Cai2026,
  author = {Cai, Yonglong and Xiang, Xuexiang and Jiang, Min and Chen, Charles and Chen, Jiwei and Lane, Nancy and Yao, Wei},
  title = {LLP2A-Ale, a Novel PDC Drug, Attenuates Osteoarthritis Progression by Modulating Subchondral Bone Remodeling and Chondroprotective Pathways in Osteoarthritis Models},
  journal = {Osteoarthritis and Cartilage},
  year = {2026},
  volume = {34},
  pages = {S61--S62},
  doi = {10.1016/j.joca.2026.01.059}
}
Kostenlos starten →